Utility Over Hype: ETF Launch Alert
This ETF isn't about speculation, it's about infrastructure. Seconds-level settlement, low fees, and institutional custody.
Luigi Mangione's court hearing continues on anniversary of UnitedHealthcare CEO's killing
NEW YORK (AP) — A high-stakes hearing in the New York murder case against continues Thursday, a year to the day after prosecutors say he gunned down UnitedHealthcare CEO .
Why Is Scholar Rock Holding Stock Climbing Today?
Scholar Rock shares jump after the company strengthened its cash runway into 2027 and advanced launch preparations for its lead drug candidate, apitegromab.
They've Done It 20+ Times-Now They've Found a New Memecoin to Watch - Ad
Our analysts have built one of the most reliable track records in the memecoin space by recognizing early momentum signals many traders overlook. Their newest pick shows several of the same early indicators found in past standout performers. Get the details before this story spreads.
Black Diamond's Lung Cancer Drug Shows 60% Response Rate In Phase 2 Data
Black Diamond posts strong Phase 2 lung cancer results with a 60% response rate and solid safety profile while preparing major trial updates and GBM expansion plans.
San Francisco sues nation's top food manufacturers over ultraprocessed foods
The city of San Francisco filed a lawsuit against some of the nation's top food manufacturers on Tuesday, arguing that ultraprocessed food from the likes of Coca-Cola and Nestle are responsible for a public health crisis.
The Repeatable Strategy Behind 20+ Early Memecoin Wins (Revealed) - Ad
Few analysts have been able to consistently spot strong memecoin setups, but our team has developed a repeatable framework that has helped them identify high-momentum plays early. Now they've uncovered a new project showing similar characteristics, and they want you to see the full breakdown yourself.
UK and US agree zero-tariff deal on pharmaceuticals
LONDON (AP) — The U.K. has secured a 0% tariff rate for all U.K. medicines exported to the U.S. for at least three years, officials said Monday, in return for the U.K. spending more on new medicines.
What is mutual aid? And why are more people turning to informal efforts to help each other?
When major disruptions happen in communities, often the first people to respond are the residents themselves and their neighbors. When the or after or wildfire, people get together to take care of each other.
$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
What's Going On With Alnylam Stock On Friday?
Alnylam stock climbs as earnings beat, sales soar and new Amvuttra data shows cardiac benefits, adding momentum to its strong 2025 run.
Some Social Security Recipients Get Double Payments In December And January
Social Security payments in Dec 2025 will be paid on Jan 30 & Dec 31. Feb's check will also come early. Retirees will receive COLA raise in Dec.
The Next ETF Era Begins with Payments - Ad
After Solana and Hedera, another digital-asset ETF has arrived and it targets global money movement.
Trump administration says lower prices for 15 Medicare drugs will save taxpayers billions
NEW YORK (AP) — Pharmaceutical companies have agreed to slash the Medicare after months of negotiations, reductions that are expected to produce billions in savings for taxpayers and older adults, the Trump administration said.
Trump EPA moves to abandon rule that sets tough standards for deadly soot pollution
WASHINGTON (AP) — The Trump administration is seeking to abandon a rule that sets tough standards for deadly , arguing that the Biden administration did not have authority to set the tighter standard on pollution from tailpipes, smokestacks and other industrial sources.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
ByHeart baby formula from all lots may be contaminated with botulism bacteria, tests show
Tests of ByHeart infant formula tied to a that has sickened dozens of babies showed that all of the company's products may have been contaminated.
AP Lifestyles Digest for week of Nov. 24
Here is the AP Lifestyles Digest for the week of Nov. 17. Note AP's Holiday Gift Guide Digest moved Nov. 12 and is included at the end.
Utility Over Hype: ETF Launch Alert - Ad
This ETF isn't about speculation, it's about infrastructure. Seconds-level settlement, low fees, and institutional custody.
These 6 kitchen tools can make or break your Thanksgiving dinner
It’s the start of week, the time when home cooks across America suddenly recognize the daunting task ahead.
Elon Musk-Led Neuralink's First Patient Details Life Post Receiving BCI Chip — Eyes Second Implant: 'It Gave Me Hope'
The first recipient of Elon Musk-led Neuralink's BCI implant shares his experiences and how it changed his life, eyeing a second implant.
The Smart Money Copper Trade - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Elanco Animal Health Stock Is Undervalued: Analyst
KeyBanc initiates Elanco with an Overweight rating, citing strong Innovation Product growth, margin gains, and a path to lower leverage.
'Rental Family' spotlights real-life Japanese businesses that offer fill-in relatives, friends
TOKYO (AP) — Ryuichi Ichinokawa's life could be right out of the movie “Rental Family” as the founder nearly two decades ago of the Heart Project business in Japan, which he bills as a surrogate attendance service complete with furnishing of extras and family members.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
UN secretary general urges nations at climate talks to be flexible to get results
BELEM, Brazil (AP) — U.N. Secretary-General António Guterres on Thursday called for countries at climate talks in Brazil to compromise and “show willingness and flexibility to deliver results,” even if they fall short of the strongest measures some nations want.
LOCALIZE IT: At least 30 babies in 15 states sickened by growing infant botulism outbreak
EDITORS/NEWS DIRECTORS:
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
Be Well: Breaking down fiber, the next food fad
U.S. consumers who have had their fill of finding to everything from cereal to ice cream are about to meet the next big food fad: fiber.
FDA Clears Arrowhead Pharma's First-Ever Home Injection For Rare Fat Disorder
Arrowhead Pharmaceuticals won FDA approval for Redemplo (plozasiran), an siRNA drug reducing high triglycerides in adults with rare FCS.
D.C.'s Quiet Plan for a New Tech Era - Ad
Why did federal agencies receive orders to "clear the runway" for a phenomenon most Americans haven't even heard of yet? And why are billionaires rushing in weeks before January 1? Whitney Tilson decoded the pattern.
Annovis Bio Stock Jumps As New Data Shows Buntanetap Halts Cognitive Decline In Parkinson's Patients
Annovis Bio rises after Phase 3 data show buntanetap halted decline in Parkinson's patients, with results in those with amyloid co-pathology.
Novo Nordisk Leans Into Affordability Amid Rising Competition
Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger Wegovy pill rollout.
They've Done It 20+ Times-Now They've Found a New Memecoin to Watch - Ad
Our analysts have built one of the most reliable track records in the memecoin space by recognizing early momentum signals many traders overlook. Their newest pick shows several of the same early indicators found in past standout performers. Get the details before this story spreads.
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
WASHINGTON (AP) — The Food and Drug Administration said Friday it will add a new warning and other limitations to a that's been linked to .
Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus
Cartesian Therapeutics shared initial data from Phase 2 trial of Descartes-08, showing potential for treating systemic lupus erythematosus.
The Repeatable Strategy Behind 20+ Early Memecoin Wins (Revealed) - Ad
Few analysts have been able to consistently spot strong memecoin setups, but our team has developed a repeatable framework that has helped them identify high-momentum plays early. Now they've uncovered a new project showing similar characteristics, and they want you to see the full breakdown yourself.
Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain
Applied Therapeutics stock falls after FDA feedback prompts another Type C meeting to discuss the Phase 3 plan for its CMT-SORD drug govorestat.
Workers take on side jobs to combat stagnant salaries and insecurity about employment
NEW YORK (AP) — As workers face , inflation and , some have decided to branch out from their traditional careers. They're taking on side jobs to bring in additional income and provide a backup plan should they , or adding second, third and sometimes fourth jobs — what some call “polyworking” — to the mix.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.